NurExone Biologic Inc. (TSXV:NRX)
0.6400
-0.0400 (-5.88%)
At close: Feb 9, 2026
10.34% (1Y)
| Market Cap | 58.04M +25.5% |
| Revenue (ttm) | n/a |
| Net Income | -9.10M |
| EPS | -0.12 |
| Shares Out | 90.68M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 26,457 |
| Average Volume | 21,895 |
| Open | 0.6700 |
| Previous Close | 0.6800 |
| Day's Range | 0.6400 - 0.6700 |
| 52-Week Range | 0.5500 - 1.1400 |
| Beta | 0.23 |
| RSI | 53.57 |
| Earnings Date | Mar 30, 2026 |